
GYRE
USDGyre Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$7.470
High
$7.470
Low
$7.250
Volume
0.06M
Company Fundamentals
Market Cap
662.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.09M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis
SAN DIEGO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (NASDAQ:GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems
Jefferies Initiates Coverage On Gyre Therapeutics with Buy Rating, Announces Price Target of $16
Jefferies analyst Roger Song initiates coverage on Gyre Therapeutics with a Buy rating and announces Price Target of $16.
Related Stocks
DELL
Dell Technologies Inc. Class C
ATSG
Air Transport Services Group Inc
PYXS
Pyxis Oncology Inc.
AGM
Federal Agricultural Mortgage Corporation
AAGRW
African Agriculture Holdings Inc. Warrant
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.